StockData
Trinity Biotech PLC logo

Trinity Biotech PLC (TRIB) stock

TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 1/30
$6.01+0.63 (+11.81%)

Close on Nov 17, 2026Market cap $112.45MP/E –Yield –

Trinity Biotech price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Trinity Biotech's price to sales ratio was 2.5× on Nov 11, 2026, against 9.1× a year earlier. Over the last 5 years it ranged from 2.5× to 12.8×, with a median of 5.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.5×−4.5
2025Dec 31, 20256.9×+3.4
2024Dec 31, 20243.6×−0.5
2023Dec 29, 20234.1×+0.7
2022Dec 30, 20223.4×−0.6
2021Dec 31, 20214.0×−28.2
2020Dec 31, 202032.2×+23.9
2019Dec 31, 20198.3×−10.4
2018Dec 31, 201818.6×−24.8
2017Dec 29, 201743.5×−13.3
2016Dec 30, 201656.8×–

More Trinity Biotech figures

See a number that looks wrong?